3 ‘Strong Buy’ Stocks Under $10 to Watch in October for 100%+ Upside
Low-priced stocks can carry high risk but also offer solid upside potential. On Wall Street, analysts currently rate three such stocks a Strong Buy...
Perspective Therapeutics Inc. (CATX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Commodore Capital Egen Atkinson And Michael Kramarz | 6,336,782 | $21,608,427 | 1.29% | |
| 2. | Avidity Partners Management David Witzke And Michael Gregory | 6,299,999 | $21,482,997 | +5% | 3.44% |
| 3. | Millennium Management Israel Englander | 4,911,855 | $16,749,426 | +22% | 0.01% |
| 4. | Citadel Investment Group Ken Griffin | 3,805,739 | $12,977,570 | +7% | 0% |
| 5. | Spruce Street Capital Alex Rosen And Simon Basseyn | 3,693,931 | $12,596,305 | +41% | 2.47% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.03 | 11,000 | $22,294.80 | 59,800 | 2025-11-13 | Filing | |
| $2.10 | 9,498 | $19,945.80 | 9,864 | 2025-11-12 | Filing | |
| $2.21 | 4,650 | $10,288.13 | 4,650 | 2025-03-28 | Filing | |
| $2.24 | 22,026 | $49,384.49 | 59,383 | 2025-03-28 | Filing | |
| $2.14 | 38,145 | $81,775.25 | 108,982 | 2025-03-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 167,149 | $526,051.33 | 11,273,364 | 2026-09-04 | Filing | |
| $3.11 | 80,783 | $250,895.84 | 11,440,513 | 2026-09-03 | Filing | |
| $3.11 | 42,129 | $131,219.20 | 11,521,296 | 2026-09-02 | Filing | |
| $3.12 | 35,769 | $111,574.24 | 11,563,425 | 2026-09-01 | Filing | |
| $3.14 | 78,145 | $245,609.74 | 11,599,194 | 2026-08-31 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 86,000 | $236,500 | 0.11% | |
| 2. | 19,061 | $52,418 | 0.01% | |
| 3. | 659 | $1,812 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Perspective Therapeutics, Inc. (CATX) Builds Momentum With Funding and Trial Progress
Perspective Therapeutics Inc. (NYSE:CATX) is one of the best high-return penny stocks to buy right now. On February 2, Perspective Therapeutics Inc.
11 Best High Return Penny Stocks to Buy Right Now
In this article, we’ll look at the 11 Best High Return Penny Stocks to Buy Right Now.
Perspective Therapeutics, Inc. (CATX) Reports Positive Results for NET Treatment Trial
Perspective Therapeutics, Inc.
13 Best Multibagger Stocks to Invest in Now
In this article, we identify the 13 Best Multibagger Stocks to invest in now.
10 Best Multibagger Stocks To Buy Heading into 2025
In this article, we discuss the 10 best multi-bagger stocks to buy heading into 2025 along with the market conditions post-election.
10 Small Cap Stocks with High Potential
In this article, we will take a detailed look at ten small cap stocks with high potential.
Hedge Fund Resource Center